HIGHLIGHTS
- who: Shringar Rao from the University of New South Wales, Australia have published the research work: Sex differences in HIV-1 persistence and the implications for a cure, in the Journal: (JOURNAL)
- how: This study however was the first ever HIV-1 cure clinical trial to be conducted exclusively in women and further work is necessary to address how latency reversal can be influenced by sex hormones like estrogen.
- future: Investigation is necessary to assess if WLHIV indeed have lower inducible reservoirs than men whether the lower MS-vRNA observed in women contributes . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.